Article

Dea Belazi, PharmD, Explains the Copay Assistance Program and Its Role in Adherence

Dea Belazi, PharmD, Vice President, Payer & Healthcare Solutions, Source Healthcare Analytics, says a copay assistance program is primarily sponsored or supported by a pharmaceutical manufacturer.

Dea Belazi, PharmD, Vice President, Payer & Healthcare Solutions, Source Healthcare Analytics, says a copay assistance program is primarily sponsored or supported by a pharmaceutical manufacturer. It is intended to provide financial assistance to those patients who require a particular brand of product made by the manufacturer. In improving adherence, a more affordable option helps patients pay for their required drugs.

“If a patient is suffering or is challenged by financial issues with costs in a particular branded product made a manufacturer, “ said Dr Belazi, “the idea is the copay program can support that and therefore make it more financially viable or affordable for the patient to get the product.”

Related Videos
John Barkett, MBA
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Tom Belmont
Pieter Sonneveld, MD, PhD
Mohit Narang, MD
 Sandeep Sahay, MD, FCCP, director of the Pulmonary Hypertension Program, Houston Methodist Hospital
Jessica Horwitz, MPH, FNP-C.
Jessica Horwitz, MPH, FNP-C.
Craig A. Portell, MD, UVA Health
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo